NCT06684457

Brief Summary

Atrial Fibrillation is a chronic disease with significant health consequences like increased risk of stroke, heart failure, heart attack and death. Educating patients about the disease is important for them to be able to understand the condition better, feel empowered and take an active part in their care plan. AI technology can potentially be used to impart such education. However, doing so with care and empathy is equally important. Therefore, it is necessary to ensure when AI technology is used to impart education about atrial fibrillation to patients, the humane aspects of the interaction are rigorously tested. This study examines a way to impart atrial fibrillation education through interaction with an AI chatbot, that uses text and links to educational videos. To participate in this study, people need to be age 18 or older and have a history of newly diagnosed atrial fibrillation. Approximately 40 individuals will be asked to take part in this study. The first step to the study will be reading through, understanding, and signing an informed consent. People who then agree to join the study will have a one-time interaction with the AI chatbot and structured educational material by using an iPad provided to them for the approximately 1 hour duration of the study. People in the study will obtain atrial fibrillation education by typing one by one on the iPad, up to 10 questions about the disease. Answers will include text and links to videos. Before and after atrial fibrillation education, people who join this study will be asked to fill out a survey. The study team will teach patients how to use the iPad and type in questions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

November 25, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2025

Completed
Last Updated

July 8, 2025

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

November 8, 2024

Last Update Submit

July 2, 2025

Conditions

Keywords

educationlifestyle modificationatrial fibrillationgenerative AIchatbotartificial intelligence

Outcome Measures

Primary Outcomes (1)

  • Empathy

    Assess patient perceived degree of empathy exhibited by chatbot responses. The degree of empathy will be measured using a pre- and post- chatbot interaction 7 point Likert scale survey, with a higher score suggesting a higher level of perceived empathy. The title of the survey will be "Likert scale based survey for perceived empathy and trust," with the lowest score being 4 and the highest score being 28. Survey form available upon reasonable request.

    From enrollment to end of interaction with chatbot, approximately an hour

Secondary Outcomes (2)

  • Knowledge

    From enrollment to end of interaction with chatbot, approximately an hour

  • Trust

    From enrollment to end of interaction with chatbot, approximately an hour

Study Arms (1)

Pilot interventional arm

EXPERIMENTAL

Single arm, wherein all consenting participants undergoing interaction with chatbot for atrial fibrillation education.

Behavioral: Atrial Fibrillation Education

Interventions

Atrial fibrillation education rendered through a generative AI chatbot, using an iPAD. The intervention itself is an approximately 1 hour long interaction with the chatbot or approximately 10 questions about atrial fibrillation, for 1 single interaction.

Pilot interventional arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than18 yrs
  • Known diagnosis of atrial fibrillation

You may not qualify if:

  • Inability to text/use an electronic device
  • Inability to read English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Heart and Vascular Institute

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Samir Saba, MD

    UPMC Heart and Vascular Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Study design: A single center, cross sectional, uncontrolled, open-label, non-randomized, single arm, experimental pilot study using an LLM based prompt-engineered education chatbot, to impart a Q and A format atrial fibrillation education to patients, prior to their first appointment with a cardiologist or a cardiac electrophysiologist. The prompt-engineered chatbot is built on LLM capabilities yet tailored with the help of physician provided, vetted, open source atrial fibrillation educational material as well as empathy enhancing scripts, and simplified language to a 6th-8th grade reading level. The chatbot would be utilized to enhance the patient-provider interaction by providing empathetic education to patients regarding atrial fibrillation, and empower them with the knowledge they would need to ask informed questions during their patient visit. The chatbot will also be able to direct patients to Heart Rhythm Society's open source educational videos for atrial fibrillation (UpBeat
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 8, 2024

First Posted

November 12, 2024

Study Start

November 25, 2024

Primary Completion

May 2, 2025

Study Completion

May 2, 2025

Last Updated

July 8, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Deidentified IPD may be shared at the discretion of investigators, upon reasonable request.

Locations